CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-01 | Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY | Option exercise · Restricted Stock Units | −9,152 | 54,918 | ||
| 2026-09-01 | Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY | Option exercise · Performance Stock Units | −426 | 2,553 | ||
| 2026-09-01 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise | +42,277 | 456,899 | ||
| 2026-09-01 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise | +1,966 | 458,865 | ||
| 2026-09-01 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −42,277 | 253,662 | ||
| 2026-09-01 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise · Performance Stock Units | −1,966 | 11,795 | ||
| 2026-09-01 | Grasher Michael F Chief Financial Officer | Grant or award · Restricted Stock Units | +239,616 | 239,616 | ||
| 2026-08-03 | Anquillare Mark V Director | Grant or award · Restricted Stock Units | +37,425 | 37,425 | ||
| 2026-07-06 | Bliss Kelly President, U.S. Group Health | Sale 10b5-1 | −2,500 | $9.50 | $24K | 84,878 |
| 2026-07-02 | Catapano Joseph Ronald Chief Accounting Officer | Sale | −653 | $9.10 | $6K | 12,267 |
| 2026-07-01 | Catapano Joseph Ronald Chief Accounting Officer | Option exercise | +2,083 | 12,920 | ||
| 2026-07-01 | Catapano Joseph Ronald Chief Accounting Officer | Option exercise · Restricted Stock Units | −2,083 | 10,418 | ||
| 2026-07-01 | Bliss Kelly President, U.S. Group Health | Sale 10b5-1 | −2,500 | $9.00 | $23K | 87,378 |
| 2026-06-29 | Bliss Kelly President, U.S. Group Health | Sale 10b5-1 | −2,500 | $8.50 | $21K | 89,878 |
| 2026-06-11 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Sale | −18,074 | $6.94 | $125K | 414,622 |
| 2026-06-10 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise | +3,642 | 393,536 | ||
| 2026-06-10 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise | +39,160 | 432,696 | ||
| 2026-06-10 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise · Performance Stock Units | −3,642 | 14,568 | ||
| 2026-06-10 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −39,160 | 156,643 | ||
| 2026-06-03 | Rodrigues Fernando M. President of BetterHelp | Sale 10b5-1 | −9,572 | $7.40 | $71K | 0 |
Page 3 of 74 · 1,476 trades